Yanina Natanzon

Dose-Response Association of CD8⁺ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

Ellen L. Goode, Matthew S. Block, Kimberly R. Kalli et al. · JAMA Oncology · 2017 · 404 citations · Full text

Medicine, Immunology, Oncology +17

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases

Nicola S. Meagher, Linyuan Wang, Peter Rambau et al. · Modern Pathology · 2019 · 99 citations · Full text

Medicine, Oncology, Pathology +16

Metabolome-based signature of disease pathology in MS

Stacy L. Andersen, Farren Briggs, Janice Winnike et al. · Multiple Sclerosis and Related Disorders · 2019 · 61 citations · Full text

Life Sciences, Neurology, Pathology +13

The Friends of Cancer Research Real‐World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies

Donna R. Rivera, Henry J. Henk, Elizabeth Garrett‐Mayer et al. · Clinical Pharmacology & Therapeutics · 2021 · 56 citations · Full text

Medicine, Oncology, Evidence-based Practice +16

Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes

Madalene A. Earp, Rama Raghavan, Qian Li et al. · Oncotarget · 2017 · 36 citations · Full text

Medicine, Molecular Genetics, Oncology +17